Epstein Secrets

ctious Diseases, Weill Medic=l College of Cornell University, New York, NY 2. Department of Microbiology and Immunology, Weill Medical College of C=rnell University, New York, NY 3. United States Army Medical Research Institute of Infectious Diseases= Frederick, MD. 4. Integrated Research Facility, Division of

evices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs

rone D.H.2, 6= Spitzer E.D.7, Barany F.2 and Golightly L.M.1, 2 1. Department of Medicine, Division of Infectious Diseases, Weill Medi=al College of Cornell University, New York, NY 2. Department of Microbiology and Immunology, Weill Medical College of=Cornell University, New York, NY 3. United States Army Medica

ricated devices that w=ll allow for electronic detection, obviating the need for expens=ve hardware used in most fluorescent detection schemes (i.e. Taqman a=says). As such, we are poised to combine these technologie= for rapidly identifying and providing quantitative viral load fo= all the VHF, Variol

Diseases, Centers for Disease Control and Prevention,&nbs=;Atlanta, GA 6. Department of Pathology and Laboratory Medicine, Weill Medical Colle=e of Cornell University, New York, NY 7. Department of Pathology, Stony Brook University Medical Center, Ston= Brook, NY ABSTRACT CDC designated category A infectious age

devices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs